全球类器官市场：依产品和服务、类器官类型、应用、最终用户和地区的预测（~2032年）

类器官市场规模预计将从2023年的13.9亿美元，2024年的16.8亿美元，到2032年将成长到91.6亿美元，预测期内年复合成长率为23.55%。由于对个人化医疗的需求不断成长以及药物发现和毒理学研究的应用不断增加，该市场不断成长。

类器官市场是由个人化医疗需求不断成长所推动的。精准医疗，也称为个人化医疗，其特点是根据每个患者的特征进行客製化治疗。该方法目的是透过考虑基因组成、环境和生活方式等因素来提供更有效、更有针对性的治疗。类器官是推动个人化医疗的重要工具，因为它们是模仿器官功能和复杂性的微型3D组织结构。

承认个体对治疗的反应存在巨大差异是个人化医疗的关键要素。儘管动物模型和二维细胞培养经常用于传统药物开发，但它们并不能准确反映人类生物学。类器官为研究疾病机制和评估药物反应提供了一个更生理相关的平台。透过利用源自患者的类器官，研究人员可以更全面地了解疾病的特征，并预测个体对不同治疗的反应。

依地域的展望

北美地区将在2023年占据最大的市场占有率，预测期内年复合成长率为 22.88%，预计到2032年将增至 34.2亿美元的规模。

技术的进步促进了 3D 类器官和球体的开发，增加了美国和加拿大生物技术领域基于类器官的研究模型的使用。美国领先的学术研究机构和生物技术公司一直处于类器官技术不断进步的前沿。

欧洲是仅次于北美的第二大市占率。欧洲对生命科学的大量投资和强大的研究基础设施是关键因素。处于类器官研究前沿的知名研究机构和生物技术公司位于英国、德国、荷兰等国家。

亚太地区经历显着成长。这是由多种显着因素所驱动的。类器官是源自干细胞和组织的小型3D器官，有潜力用于再生医学应用、药物发现和疾病建模。

本报告调查了全球类器官市场，提供市场的定义和概述，市场成长的各种影响因素分析，市场规模推移和预测，各种区分、地区的细分，竞争环境，主要企业概况等彙整资料。

目次

第1章 执行摘要

第2章 市场概要

第3章 研究方法

第4章 市场力学

• 促进要因
  • 对个人化医疗的需求不断成长
  • 扩大药物发现与毒性研究的应用
• 抑制要因
  • 影响市场成长的监理挑战
  • 开发维护成本高
• 机会
  • 技术进步促进类器官的生产与应用
• 倾向
  • 加大对再生医学的投资
  • 扩大在发育生物学研究的应用
• 课题
  • 围绕类器官采购和实验的道德问题
  • 与现有医疗实践和技术整合的挑战
• 新冠肺炎（COVID-19）影响分析

第5章 市场要因分析

• 价值链分析
• 波特五力分析

第6章 全球类器官市场：依产品与服务分类

• 概要
• 製品
• 服务

第7章 全球类器官市场：依类器官类型

• 概要
• 肝臟
• 肾臟
• 胰臟
• 肠
• 心
• 其他

第8章 全球类器官市场：依应用

• 概要
• 药物测试
• 发育生物学
• 个人化医疗
• 再生医学
• 其他

第9章 全球类器官市场：依最终用户

• 概要
• 学术/研究机构
• 製药/生物公司
• 合约研究组织
• 其他

第10章 全球类器官市场：依地区

• 世界
• 北美
• 欧洲
• 亚太地区
• 其他领域

第11章 竞合情势

• 比赛概览
• 全球类器官市场的主要参与者
• 竞争基准测试
• 主要发展与成长策略

第12章 公司简介

• HUB ORGANOIDS
• NEYROBLASTGX
• STEMCELL TECHNOLOGIES
• BIO-TECHNE
• THERMO FISHER SCIENTIFIC INC
• 3DNAMICS INC.
• MOLECULAR DEVICES, LLC
• MERCK KGGA
• CORNING INCORPORATED
• CN BIO INNOVATIONS LTD

第13章 资料引用

Global Organoids Market Research Report Information By Product and Service (Product and Service), By Type of Organoids (Liver, Kidney, Pancreas, Intestine, Heart, and others), By Application (Drug Testing, Developmental Biology, Personalized Medicine, Regenerative Medicine, and Others), By End-Users (Academic and Research Institutes, Pharmaceutical and Biotechnology Company, Contract Research Organizations (CROs), and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) -Forecast Till 2032

Market Overview

In 2023, the Organoids Market was estimated to be worth USD 1.39 billion. The industry is anticipated to experience a compound annual growth rate (CAGR) of 23.55% from USD 1.68 billion in 2024 to USD 9.16 billion by 2032 during the forecast period (2024-2032). The market is experiencing growth due to the increasing demand for personalized medicine and the increasing application of drug discovery and toxicology studies.

The Organoids Market is being driven by the increasing demand for personalized medicine. Precision medicine, which is also referred to as personalized medicine, is characterized by the customization of medical treatment to the unique characteristics of each patient. This method is designed to deliver more effective and targeted therapies by taking into account factors such as genetic composition, environment, and lifestyle. Organoids are a critical instrument in the advancement of personalized medicine, as they are miniature 3D tissue structures that replicate the functionality and complexity of organs.

The acknowledgment of the significant variability in the way individuals respond to treatments is a critical component of personalized medicine. Animal models or 2D cell cultures are frequently employed in conventional drug development methods, but they do not accurately reflect human biology. Organoids provide a more physiologically relevant platform for the investigation of disease mechanisms and the assessment of drug responses. Researchers can gain a more comprehensive understanding of the distinctive characteristics of diseases and predict the responses of individuals to various treatments by utilizing patient-derived organoids.

Market segment insights

The Organoids Market has been segmented into product and service based on product and service.

The Organoids Market has been segmented into the following categories: Liver, Kidney, Pancreas, Intestine, Heart, and Others according to the variety of organoids.

The Market has been segmented into Drug Testing, Developmental Biology, Personalized Medicine, Regenerative Medicine, and Others, as determined by its application.

The Market has been segmented into Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and others based on End-Users.

Regional Perspectives

The Organoids Market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World based on region. In 2023, North America held the largest market share, which is expected to increase to USD 3.42 billion by 2032, representing a compound annual growth rate (CAGR) of 22.88% during the forecast period.

Advancements in technology have facilitated the development of 3D organoids and spheroids, which have contributed to the rise in the use of organoid-based research models in the biotechnology sector of the United States and Canada. Major academic research institutions and biotechnology companies in the United States have been at the vanguard of the ongoing advancement of organoid technology.

Europe is the second-largest organoid market share, following the Americas region. Europe's substantial investment in life sciences and robust research infrastructure are significant factors. Renowned research institutions and biotechnology corporations that are at the forefront of organoid research are located in countries such as the United Kingdom, Germany, and the Netherlands.

The organoids market in the Asia Pacific region is experiencing substantial growth, which is being promoted by a variety of notable factors. Organoids, miniaturized organs that are three-dimensional and are derived from stem cells or tissue, have the potential to be used in regenerative medicine applications, drug discovery, and disease modeling.

Major Players

Merck KGgA, Corning Incorporated, STEMCELL Technologies, Bio-Techne, Molecular Devices, LLC, and Thermo Fisher Scientific Inc. are among the major participants in the Organoids Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 Data Mining Process
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 Secondary Research data flow:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 Primary Research DATA FLOW:
  • 3.5.2 Primary Research: Number of Interviews conducted
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 Revenue Analysis Approach
• 3.7 DATA FORECASTING
  • 3.7.1 Data forecasting Type
• 3.8 DATA MODELING
  • 3.8.1 microeconomic factor analysis:
  • 3.8.2 Data modeling:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 Rising demand for personalized medicine
  • 4.2.2 Growing applications in drug discovery and toxicology studies
• 4.3 RESTRAINTS
  • 4.3.1 Regulatory challenges impacting market growth
  • 4.3.2 High cost of development and maintenance
• 4.4 OPPORTUNITY
  • 4.4.1 Technological advancements enhancing organoid production and applications
• 4.5 TREND
  • 4.5.1 Rising investment in regenerative medicine
  • 4.5.2 Expanding use in studying developmental biology
• 4.6 CHALLENGES
  • 4.6.1 Ethical concerns surrounding organoid sourcing and experimentation
  • 4.6.2 Integration challenges with existing medical practices and technologies
• 4.7 IMPACT ANALYSIS OF COVID-19
  • 4.7.1 Impact on R & D
  • 4.7.2 Impact on Supply Chain
  • 4.7.3 Impact on Pricing

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 Raw Material Sourcing and Research & Development (R&D)
  • 5.1.2 Organoid Production and Quality Control/Assurance
  • 5.1.3 Distribution and Logistics
  • 5.1.4 Application in Research, Drug Discovery, and Clinical Translation
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 Threat of New Entrants
  • 5.2.2 Bargaining Power of Suppliers
  • 5.2.3 Threat of Substitutes
  • 5.2.4 Bargaining Power of Buyers
  • 5.2.5 Intensity of Rivalry

6 GLOBAL ORGANOIDS MARKET, BY PRODUCT & SERVICE

• 6.1 OVERVIEW

7 GLOBAL ORGANOIDS MARKET, BY TYPE OF ORGANOIDS

• 7.1 OVERVIEW

8 GLOBAL ORGANOIDS MARKET, BY APPLICATION

• 8.1 OVERVIEW

9 GLOBAL ORGANOIDS MARKET, BY END-USERS

• 9.1 OVERVIEW

10 GLOBAL ORGANOIDS MARKET, BY REGION

• 10.1 GLOBAL
• 10.2 NORTH AMERICA
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 EUROPE
  • 10.3.1 germany
  • 10.3.2 France
  • 10.3.3 UK
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Rest of Europe
• 10.4 ASIA PACIFIC
  • 10.4.1 china
  • 10.4.2 India
  • 10.4.3 Japan
  • 10.4.4 South Korea
  • 10.4.5 Australia
  • 10.4.6 Rest of Asia Pacific
• 10.5 REST OF THE WORLD
  • 10.5.1 Middle East & Africa
  • 10.5.2 South America

11 COMPETITIVE LANDSCAPE

• 11.1 COMPETITIVE OVERVIEW
• 11.2 MAJOR PLAYERS IN THE GLOBAL ORGANOIDS MARKET
• 11.3 COMPETITIVE BENCHMARKING
• 11.4 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 11.4.1 Product launch/development
  • 11.4.2 Contract & Agreement

12 COMPANY PROFILES

• 12.1 HUB ORGANOIDS
  • 12.1.1 Company Overview
  • 12.1.2 FINANCIAL OVERVIEW
  • 12.1.3 Products/Services Offered
  • 12.1.4 KEY DEVELOPMENTS
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Strategies
• 12.2 NEYROBLASTGX
  • 12.2.1 COMPANY OVERVIEW
  • 12.2.2 FINANCIAL OVERVIEW
  • 12.2.3 PRODUCTS OFFERED
  • 12.2.4 KEY DEVELOPMENTS
  • 12.2.5 SWOT ANALYSIS
  • 12.2.6 KEY STRATEGIES
• 12.3 STEMCELL TECHNOLOGIES
  • 12.3.1 COMPANY OVERVIEW
  • 12.3.2 FINANCIAL OVERVIEW
  • 12.3.3 PRODUCTS OFFERED
  • 12.3.4 KEY DEVELOPMENTS
  • 12.3.5 SWOT ANALYSIS
  • 12.3.6 KEY STRATEGIES
• 12.4 BIO-TECHNE
  • 12.4.1 COMPANY OVERVIEW
  • 12.4.2 Financial Overview
  • 12.4.3 PRODUCTS OFFERED
  • 12.4.4 Key Developments
  • 12.4.5 SWOT ANALYSIS
  • 12.4.6 KEY STRATEGIES
• 12.5 THERMO FISHER SCIENTIFIC INC
  • 12.5.1 COMPANY OVERVIEW
  • 12.5.2 Financial Overview
  • 12.5.3 PRODUCTS OFFERED
  • 12.5.4 KEY DEVELOPMENTS
  • 12.5.5 SWOT ANALYSIS
  • 12.5.6 KEY STRATEGIES
• 12.6 3DNAMICS INC.
  • 12.6.1 COMPANY OVERVIEW
  • 12.6.2 FINANCIAL OVERVIEW
  • 12.6.3 PRODUCTS OFFERED
  • 12.6.4 KEY DEVELOPMENTS
  • 12.6.5 SWOT ANALYSIS
  • 12.6.6 KEY STRATEGIES
• 12.7 MOLECULAR DEVICES, LLC
  • 12.7.1 Company Overview
  • 12.7.2 FINANCIAL OVERVIEW
  • 12.7.3 Products/Services Offered
  • 12.7.4 Key Developments
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Strategies
• 12.8 MERCK KGGA
  • 12.8.1 COMPANY OVERVIEW
  • 12.8.2 Financial Overview
  • 12.8.3 PRODUCTS OFFERED
  • 12.8.4 KEY DEVELOPMENTS
  • 12.8.5 SWOT ANALYSIS
  • 12.8.6 KEY STRATEGIES
• 12.9 CORNING INCORPORATED
  • 12.9.1 COMPANY OVERVIEW
  • 12.9.2 Financial Overview
  • 12.9.3 PRODUCTS OFFERED
  • 12.9.4 KEY DEVELOPMENTS
  • 12.9.5 SWOT ANALYSIS
  • 12.9.6 KEY STRATEGIES
• 12.10 CN BIO INNOVATIONS LTD
  • 12.10.1 COMPANY OVERVIEW
  • 12.10.2 FINANCIAL OVERVIEW
  • 12.10.3 PRODUCTS OFFERED
  • 12.10.4 KEY DEVELOPMENTS
  • 12.10.5 SWOT ANALYSIS
  • 12.10.6 KEY STRATEGIES

13 DATA CITATIONS

LIST OF TABLES

• TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
• TABLE 2 GLOBAL ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 3 GLOBAL ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 4 GLOBAL ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 5 GLOBAL ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 6 GLOBAL ORGANOIDS MARKET, BY REGION, 2020-2032 (USD MILLION)
• TABLE 7 NORTH AMERICA: ORGANOIDS MARKET, BY COUNTRY, 2020-2032 (USD MILLION)
• TABLE 8 NORTH AMERICA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 9 NORTH AMERICA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 10 NORTH AMERICA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 11 NORTH AMERICA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 12 US ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 13 US ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 14 US ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 15 US ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 16 CANADA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 17 CANADA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 18 CANADA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 19 CANADA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 20 MEXICO ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 21 MEXICO ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 22 MEXICO ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 23 MEXICO ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 24 EUROPE: ORGANOIDS MARKET, BY COUNTRY, 2020-2032 (USD MILLION)
• TABLE 25 EUROPE ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 26 EUROPE ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 27 EUROPE ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 28 EUROPE ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 29 GERMANY ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 30 GERMANY ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 31 GERMANY ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 32 GERMANY ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 33 FRANCE ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 34 FRANCE ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 35 FRANCE ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 36 FRANCE ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 37 UK ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 38 UK ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 39 UK ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 40 UK ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 41 SPAIN ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 42 SPAIN ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 43 SPAIN ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 44 SPAIN ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 45 ITALY ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 46 ITALY ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 47 ITALY ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 48 ITALY ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 49 REST OF EUROPE ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 50 REST OF EUROPE ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 51 REST OF EUROPE ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 52 REST OF EUROPE ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 53 ASIA PACIFIC: ORGANOIDS MARKET, BY COUNTRY, 2020-2032 (USD MILLION)
• TABLE 54 ASIA PACIFIC ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 55 ASIA PACIFIC ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 56 ASIA PACIFIC ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 57 ASIA PACIFIC ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 58 CHINA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 59 CHINA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 60 CHINA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 61 CHINA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 62 INDIA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 63 INDIA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 64 INDIA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 65 INDIA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 66 JAPAN ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 67 JAPAN ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 68 JAPAN ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 69 JAPAN ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 70 SOUTH KOREA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 71 SOUTH KOREA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 72 SOUTH KOREA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 73 SOUTH KOREA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 74 AUSTRALIA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 75 AUSTRALIA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 76 AUSTRALIA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 77 AUSTRALIA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 78 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 79 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 80 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 81 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 82 REST OF THE WORLD: ORGANOIDS MARKET, BY COUNTRY, 2020-2032 (USD MILLION)
• TABLE 83 REST OF THE WORLD ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 84 REST OF THE WORLD ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 85 REST OF THE WORLD ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 86 REST OF THE WORLD ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 87 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 88 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 89 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 90 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 91 SOUTH AMERICA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020-2032 (USD MILLION)
• TABLE 92 SOUTH AMERICA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020-2032 (USD MILLION)
• TABLE 93 SOUTH AMERICA ORGANOIDS MARKET, BY APPLICATION, 2020-2032 (USD MILLION)
• TABLE 94 SOUTH AMERICA ORGANOIDS MARKET, BY END-USERS, 2020-2032 (USD MILLION)
• TABLE 95 MAJOR PLAYERS IN THE GLOBAL ORGANOIDS MARKET
• TABLE 96 PRODUCT LAUNCH/DEVELOPMENT
• TABLE 97 CONTRACT & AGREEMENT
• TABLE 98 HUB ORGANOIDS: PRODUCTS/SERVICES OFFERED
• TABLE 99 NEYROBLASTGX: PRODUCTS OFFERED
• TABLE 100 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED
• TABLE 101 STEMCELL TECHNOLOGIES: KEY DEVELOPMENTS
• TABLE 102 BIO-TECHNE: PRODUCTS OFFERED
• TABLE 103 BIO-TECHNE: KEY DEVELOPMENTS
• TABLE 104 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED
• TABLE 105 3DNAMICS INC.: PRODUCTS OFFERED
• TABLE 106 MOLECULAR DEVICES, LLC: PRODUCTS/SERVICES OFFERED
• TABLE 107 MOLECULAR DEVICES, LLC: KEY DEVELOPMENTS
• TABLE 108 MERCK KGGA: PRODUCTS OFFERED
• TABLE 109 CORNING INCORPORATED: PRODUCTS OFFERED
• TABLE 110 CN BIO INNOVATIONS LTD: PRODUCTS OFFERED

LIST OF FIGURES

• FIGURE 1 GLOBAL ORGANOIDS MARKET: EXECUTIVE SUMMARY
• FIGURE 2 GLOBAL ORGANOIDS MARKET: STRUCTURE
• FIGURE 3 GLOBAL ORGANOIDS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
• FIGURE 4 VALUE CHAIN ANALYSIS OF THE GLOBAL ORGANOIDS MARKET
• FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ORGANOIDS MARKET
• FIGURE 6 GLOBAL ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2023 & 2032(USD MILLION)
• FIGURE 7 GLOBAL ORGANOIDS MARKET SHARE (%), BY PRODUCT & SERVICE,
• FIGURE 8 GLOBAL ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2023 & 2032(USD MILLION)
• FIGURE 9 GLOBAL ORGANOIDS MARKET SHARE (%), BY TYPE OF ORGANOIDS,
• FIGURE 10 GLOBAL ORGANOIDS MARKET, BY APPLICATION, 2023 & 2032(USD MILLION)
• FIGURE 11 GLOBAL ORGANOIDS MARKET SHARE (%), BY APPLICATION,
• FIGURE 12 GLOBAL ORGANOIDS MARKET, BY END-USERS, 2023 & 2032(USD MILLION)
• FIGURE 13 GLOBAL ORGANOIDS MARKET SHARE (%), BY END-USERS,
• FIGURE 14 GLOBAL ORGANOIDS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
• FIGURE 15 GLOBAL ORGANOIDS MARKET SHARE, BY REGION, 2023 (% SHARE)
• FIGURE 16 NORTH AMERICA: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 17 NORTH AMERICA: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 18 EUROPE: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 19 EUROPE: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 20 ASIA PACIFIC: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 21 ASIA PACIFIC: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 22 REST OF THE WORLD: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
• FIGURE 23 REST OF THE WORLD: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 24 BENCHMARKING OF MAJOR COMPETITORS
• FIGURE 25 HUB ORGANOIDS: SWOT ANALYSIS
• FIGURE 26 NEYROBLASTGX: SWOT ANALYSIS
• FIGURE 27 STEMCELL TECHNOLOGIES: SWOT ANALYSIS
• FIGURE 28 BIO-TECHNE: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 29 BIO-TECHNE: SWOT ANALYSIS
• FIGURE 30 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 31 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS
• FIGURE 32 3DNAMICS INC.: SWOT ANALYSIS
• FIGURE 33 MOLECULAR DEVICES, LLC: SWOT ANALYSIS
• FIGURE 34 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 35 MERCK KGGA: SWOT ANALYSIS
• FIGURE 36 CORNING INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 37 CORNING INCORPORATED: SWOT ANALYSIS
• FIGURE 38 CN BIO INNOVATIONS LTD: SWOT ANALYSIS